Cancer surveillance

Cancer surveillance has been studied in 4 papers since 2021: 2 observational studies in people, 1 review; 3 in the past year. The newest paper, Oct 9, 2026: “IMPLEMENTATION OF A DYNAMIC SURVEILLANCE PROGRAM FOR EARLY CANCER DETECTION IN HEALTHY INDIVIDUALS CARRYING PATHOGENIC VARIANTS”.

4 papers study it1 findingUpdated Oct 9, 2026

2 new papers in 30 daysSee all 4

What did studies of Cancer surveillance find?

Studies of Cancer surveillance measured 1 outcome; the most studied are Residual risk (1 study).

Residual risk

downin silico1

1 study

Cancer surveillance decreases residual risk in silico (modeled improved surveillance adequacy in RMTI framework) (30–44%).
“modeling improved surveillance adequacy reduced residual risk by 30–44%”
In silicomodeled improved surveillance adequacy in RMTI framework
The Risk Mechanism Theory Index (RMTI) as a Triage and Evidence-Grading Layer for Hepatocellular-Carcinoma Surveillance A transparent, computable model for the diagnosis-to-detection-to-management cascade, with an open calculator and a real-data demonstration
Research SquareJul 28, 2026Preprint

6 grants since 2016

National Cancer Institute$4.1MNational Institute for Health Research£1.5MMedical Research Future FundA$983K

3 papers in 12 months

Gastroenterology Clinics of North AmericaOct 27

Problemy Sotsial'noi Gigieny, Zdravookhraneniia I Istorii MeditsinyOct 9

Cohort study of 986 peopleCancer

Research SquareJul 30

Preprint: study in peopleHepatocellular carcinoma

JAMA Network OpenSep 10

Computational studyLynch syndrome